Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yanyi Zhu
Observed name:
Yan-Yi Zhu
Institution:
Array BioPharma (United States)
Observed institutions:
Memorial University of Newfoundland,
Array BioPharma (United States),
AstraZeneca (United States)
OpenAlex ID:
A5111629245
Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors
2011
·
Lewis Whitehead
, Markus R. Dobler
, et al.
·
Bioorganic & Medicinal Chemistry
·
178
(−)-Spiro[1-azabicyclo[2.2.2]octane-3,5‘-oxazolidin-2‘-one], a Conformationally Restricted Analogue of Acetylcholine, Is a Highly Selective Full Agonist at the α7 Nicotinic Acetylcholine Receptor
2000
·
George Mullen
, James Napier
, et al.
·
Journal of Medicinal Chemistry
·
147
Relieving Autophagy and 4EBP1 from Rapamycin Resistance
2011
·
Beat Nyfeler
, Philip Bergman
, et al.
·
Molecular and Cellular Biology
·
99
Identification of 4-Aminopyrazolylpyrimidines as Potent Inhibitors of Trk Kinases
2008
·
Tao Wang
, Michelle L. Lamb
, et al.
·
Journal of Medicinal Chemistry
·
81
Enantio- and diastereoselectivity in the reduction of spiro[4.5]decane-1,4-dione derivatives with baker's yeast
1996
·
Yan-Yi Zhu
, D. Jean Burnell
·
Tetrahedron Asymmetry
·
28
Identification of inhibitors of heparin–growth factor interactions from combinatorial libraries of four-component condensation reactions
2001
·
Jundong Zhang
, Georgiana Rivers
, et al.
·
Bioorganic & Medicinal Chemistry
·
24
A synthetic study of some triquinane natural products and microbial reduction of prochiral spirodiketones
1993
·
Yanyi Zhu
·
Memorial University Research Repository (Memorial University)
PDF
Show more works
View as search
Works count:
7
Citation count:
557
H-index:
6
I10-index:
6
Year
Topic
Type